Therapeutic efficacy of traditional Chinese medicine compound in the treatment of membranous nephrop

来源 :海南医科大学学报(英文版) | 被引量 : 0次 | 上传用户:w198911154
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: Systematic review of the clinical efficacy of medicinal nephropathy in the treatment of membranous nephropathy with the addition of traditional Chinese herbal compound on the basis of hormone and immunosuppressive therapy. Methods: Computer search of China Knowledge Network, Wanfang Database, Weipu Database, China Biomedical Database, PubMed Database、Embase Database、Cochrane Database, collect clinical research on Chinese medicine compound + hormone + immunosuppressive therapy for MN, delete duplicate literature, eliminate non-conformity by reading topic, abstract and full text The literature was included in the exclusion criteria, the data was extracted from the included literature, and the meta-analysis was performed using the stata14.0 software package. Results: The top 6 Chinese medicines used were Astragalus, Poria, Atractylodes, Salvia, Angelica and Chinese Yam. The use of traditional Chinese medicine in the treatment of patients with MN on the basis of hormone and immunosuppressive therapy can improve clinical efficacy[OR=2.90,95%CI(2.27, 3.70),P < 0.00001]and TCM symptom efficacy [OR=3.10,95%CI(1.91, 5.05),P < 0.00001], improved TCM syndrome scores [SMD=-0.93,95%CI(-1.34, -0.52),P < 0.00001], reduced 24-hour urine protein levels[SMD=-0.90,95%CI(-1.23, -0.57),P < 0.00001], increased plasma albumin levels[SMD=1.22,95%CI(0.86, 1.58),P = 0.000], decreased blood lipid TC levels[SMD=-0.69,95%CI(-0.98, -0.39),P< 0.00001], lowering blood lipid TG levels[SMD=-0.75,95%CI (-1.09, -0.41),P < 0.0001], in improving renal function BUN levels[SMD=-0.56,95%CI (-0.97, 0.14),P = 0.008] and Scr levels [SMD=-0.58,95%CI(-0.89, -0.27),P = 0.0002], reducing the incidence of adverse reactions [OR=0.25,95%CI(0.17, 0.36),P < 0.00001]. Egger and harbord test results suggest that some indicators have publication bias. Conclusion: The traditional Chinese medicine used is mainly jaundice, and the traditional Chinese medicine for replenishing qi and activating blood is used more frequently. In the basic application of hormone + immunosuppressive agents, Yiqihuoxue Chinese medicine has a good effect on MN, but it is limited to the quality of the included literature. The conclusion needs to be verified by more high-quality studies.
其他文献
Objective: The aim of this study was to use network pharmacology to predict the targets and related signaling pathways of turmeric in the treatment of liver can
[目的]探讨栝楼桂枝汤加减治疗中风肢体痉挛的临床效果观察及对脑血流动力学指标的影响.[方法]选取2017年1月至2019年7月本院收治的108例中风肢体痉挛患者,根据治疗方法将其
[目的]探讨地佐辛对腹腔镜胃癌根治术患者的镇痛效果及炎性因子白介素-6(IL-6)、白介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)的影响.[方法]本院收治的90例行腹腔镜胃癌根治术
[目的]探讨磷酸化tau蛋白(p-tau)和胶质纤维酸性蛋白(GFAP)检测对新生儿缺氧缺血性脑病(HIE)脑损伤程度的早期诊断价值.[方法]选取2016年6月至2018年8月在本院分娩的63例H IE
[目的]探讨数字减影血管造影(DSA)介入融通疗法治疗早期股骨头坏死的临床疗效.[方法]选择2016年1月至2017年6月在本院诊治的118例早期股骨头坏死患者,根据治疗方法不同分为观
[目的]探讨高龄产妇极早期和早期早产并发症及母婴结局.[方法]选择2018年3月至2019年6月在上海市静安区江宁路街道社区卫生服务中心分娩的高龄产妇78例病例作为研究对象,依据
目的:探究髋臼骨折手术后影响疗效的预后因素及其相关性.方法:查阅文献后,设定9个假定的预后因素(骨折类型、复位程度、局部并发症、异位骨化、患者的性别、年龄、有否髋关节脱
会议
[目的]探讨miRNA-221-3p表达对冠心病患者的诊断价值.[方法]选择2018年5~11月本院收治的400例行冠脉造影检查的疑似冠心病(CHD)患者,其中290例经冠脉造影检查诊断为CHD患者(观
一间昏暗的铺满塌塌米的斗室,两只偌大的皮箱,还有一袋刚从超级市场买来的面包,组成了我开始留学新生活的全部条件。现代化的交通工具迅速地把人的躯体带到一个新的空间,而